NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
Back to search
Official data from USPTO
NUCLEOLARON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NUCLEOLARON
ST13
US500000097482649Class
1, 5
Filing
97482649
Registration
7061973
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
05/23/2023
Trademark type
Word
Nice classes
1, 5
Filing date
06/30/2022
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
05/23/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
MINATO-KU, TOKYO, JP
Examiner
MEBANE, ANASTASIA XAVIERA
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TOAGOSEI CO., LTD.
Representatives
Boris Umansky LADAS & PARRY LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific and research use; Chemical reagentsother than for medical or veterinary purpose; Biochemical reagents used for non-medical purposes; Biochemical preparations for scientific purposes; Chemical preparations for transferring moleculessuch as peptidessiRNA or DNAinto cellsfor use in industry and scientific purposes; Chemicals used in industry and science
Class 5
Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Medicinal preparations for the treatment of muscular dystrophymuscle diseases and disordersneurological diseases and disordersneuromuscular diseases and disorderscancerheart diseases and disordersbrain diseases and disorders; Pharmaceutical preparations for the treatment of muscular dystrophymuscle diseases and disordersneurological diseases and disordersneuromuscular diseases and disorderscancerheart diseases and disordersbrain diseases and disorders; Pharmaceuticals for the treatment of muscular dystrophymuscle diseases and disordersneurological diseases and disordersneuromuscular diseases and disorderscancerheart diseases and disordersbrain diseases and disorders; Medicines for the treatment of muscular dystrophymuscle diseases and disordersneurological diseases and disordersneuromuscular diseases and disorderscancerheart diseases and disordersbrain diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Medicinal preparations for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/02/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/25/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/22/2022
GNRT
NON-FINAL ACTION E-MAILED
10/22/2022
CNRT
NON-FINAL ACTION WRITTEN
10/22/2022
DOCK
ASSIGNED TO EXAMINER
10/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2022
NWAP
NEW APPLICATION ENTERED
07/04/2022
Continuous trademark protection
Get notified about every new filing that threatens NUCLEOLARON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.